Globus Medical GMED Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 67.4%+8.5pp | 58.9%-6.2pp | 65.1%-9.2pp | 74.2%-0.8pp | |
| Operating margin | 16.3%+9.7pp | 6.6%-1.9pp | 8.5%-13.8pp | 22.3%+4.3pp | |
| Net margin | 18.3%+14.2pp | 4.1%-3.7pp | 7.8%-10.8pp | 18.6%+3.0pp | |
| Returns | |||||
| Return on equity | 12.3%+9.8pp | 2.5%-1.7pp | 4.2%-6.4pp | 10.6%+1.4pp | |
| Return on invested capital | 11.1%+6.5pp | 4.7%+1.0pp | 3.7%-7.3pp | 11%+0.9pp | |
| Efficiency | |||||
| Asset turnover | 0.6×+0.1× | 0.5×0.0× | 0.4×-0.1× | 0.5×0.0× | |
| Liquidity | |||||
| Current ratio | 4.3×+1.7× | 2.5×-2.3× | 4.9×-1.3× | 6.2×0.0× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -0.5×+1.1× | -1.6×-0.3× | -1.3×-0.8× | -0.5×+0.3× | |
| Per Share | |||||
| Book value per share | $33.37+10.1% | $30.30-13.1% | $34.88+93.9% | $17.99+7.0% | |
| Valuation | |||||
| Market capitalization | $11.69B+3.8% | $11.26B+53.4% | $7.34B-1.0% | $7.42B+1.2% | |
| Price / earnings | 21.7×-87.6× | 109.4×+49.6× | 59.8×+20.8× | 39×-10.1× | |
| Price / sales | 4×-0.5× | 4.5×-0.2× | 4.7×-2.6× | 7.2×-0.4× | |
| Price / book | 2.6×-0.1× | 2.7×+0.9× | 1.8×-2.2× | 4×-0.2× | |
| EV / EBITDA | 14.9×-10.3× | 25.2×+0.2× | 25×+0.5× | 24.5×-5.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Globus Medical's profit margins?
- Globus Medical (GMED) runs a 67.9% gross margin and a 17.2% operating margin, with a 18.9% net margin.
- Where do Globus Medical's ratios come from?
- Every ratio is computed from Globus Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
